A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Clinical trial NCT01230827 · TERMINATED
Trial details
- NCT number
- NCT01230827
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-09-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.